pharmachologic effect
Symbiolact compositum has a normalizing effect on the intestinal microflora: it maintains and regulates the physiological balance of the intestinal microflora (microbiocenosis) and ensures its physiological functions in the intestine.
The therapeutic effect of Symbiolact compositum is determined by living lactobacilli and bifidobacteria, which act as antagonists against a wide range of pathogenic and opportunistic microorganisms. Lactic acid bacteria, which are part of Symbiolact Compositum, produce lactic and, to a lesser extent, acetic and propylene acid. The acidic environment created in the intestines is unfavorable for the development of pathogenic and opportunistic microorganisms. Lactic acid bacteria are involved in the resorption of monosaccharides, the metabolism of bile acids, stabilize the membranes of intestinal epithelial cells and regulate the absorption of electrolytes and the synthesis of vitamins (vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin K, vitamin E, vitamin PP, ascorbic acid, biotin) ; create favorable conditions for the absorption of iron, calcium, vitamin D (vitamin D2, vitamin D3). The use of Symbiolact compositum facilitates the digestion of proteins; Bifidobacterium phosphoprotein phosphatase is involved in the metabolism of milk casein. The activity of intestinal microflora can be disrupted due to a number of factors: taking certain medications (antibiotics, laxatives); unbalanced diet with a large amount of industrially prepared and high-calorie foods containing few ballast substances; stress and tension, smoking and alcohol abuse; intoxication with substances coming from the environment. The consequence of all this may be a violation of the harmonious balance of the microflora composition.
Symbiolact compositum 2g No. 30 - Instructions
Package
The package contains 30 sachets of 2 g.
Release form
Powder for solution for oral administration
Compound
2 grams of powder contains: lyophilized mixture of cultures of probiotic and lactic acid microorganisms (microbial mass of bifidobacteria and lactobacilli): Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis, Lactobacillus salivarius.
pharmachologic effect
Symbiolact Compositum is a dietary supplement; probiotic to maintain healthy microflora. Symbiolact compositum has a normalizing effect on the intestinal microflora: it maintains and regulates the physiological balance of the intestinal microflora (microbiocenosis) and ensures its physiological functions in the intestine.
The therapeutic effect of Symbiolact compositum is determined by living lactobacilli and bifidobacteria, which act as antagonists against a wide range of pathogenic and opportunistic microorganisms.
Lactic acid bacteria, which are part of Symbiolact Compositum, produce lactic and, to a lesser extent, acetic and propylene acid. The acidic environment created in the intestines is unfavorable for the development of pathogenic and opportunistic microorganisms. Lactic acid bacteria are involved in the resorption of monosaccharides, the metabolism of bile acids, stabilize the membranes of intestinal epithelial cells and regulate the absorption of electrolytes and the synthesis of vitamins (vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin K, vitamin E, vitamin PP, ascorbic acid, biotin) ; create favorable conditions for the absorption of iron, calcium, vitamin D (vitamin D2, vitamin D3).
The use of Symbiolact compositum facilitates the digestion of proteins; Bifidobacterium phosphoprotein phosphatase is involved in the metabolism of milk casein.
The activity of intestinal microflora can be disrupted due to a number of factors: taking certain medications (antibiotics, laxatives); unbalanced diet with a large amount of industrially prepared and high-calorie foods containing few ballast substances; stress and tension, smoking and alcohol abuse; intoxication with substances coming from the environment. The consequence of all this may be a violation of the harmonious balance of the microflora composition.
Indications for use
Symbiolact compositum is intended for the treatment of adults and children, starting from the first days of life. Symbiolact compositum is used both as monotherapy and as part of complex microbiological therapy: - intestinal dysbiosis (intestinal dysbiosis), including due to the use of antibiotics, sulfa drugs and other chemotherapeutic agents; — chronic colitis of various etiologies, including nonspecific ulcerative colitis and Crohn’s disease; - previous acute intestinal infections; — chronic enterocolitis; - irritable bowel syndrome; - traveler's diarrhea, acute diarrhea; - constipation, flatulence; — sanitation of the genital tract for nonspecific inflammatory diseases of the genitals; — prenatal preparation of pregnant women at risk with violation of vaginal cleanliness of the III-IV degree; — chronic infections of the genitourinary system (cystitis, prostatitis, vaginitis, urethritis); - mycoses of the oral cavity, intestines, skin, nails, hair, vagina; — chronic and recurrent diseases of the respiratory tract and ENT organs (bronchitis, rhinitis, sinusitis, tonsillitis, otitis media); — atopic diseases (atopic dermatitis/neurodermatitis, allergic rhinoconjunctivitis, bronchial asthma); — allergies (including food allergies), allergosis; - chronic inflammatory skin diseases (acne, furunculosis).
Directions for use and doses
Adults: mix the contents of 1 sachet of Symbiolact compositum (2 g) with 1/2 glass of water (100 ml) at room temperature and take 1-2 times a day with food. Children: mix with warm milk or water (100 ml) and take 1 time per day with food. For infants - immediately before breastfeeding, mixed with breast milk. Single doses of Symbiolact compositum for children (for 1 dose): from the first days of life to 6 months – 1/6 sachet; from 6 months to 2 years – 1/4 sachet; from 2 to 6 years - 1/3 sachet; from 6 to 10 years – 1/2 sachet; over 10 years – 1 sachet. As a rule, the course of treatment with Symbiolact compositum is from 4 to 8 weeks: intestinal dysbiosis (dysbacteriosis) - 4-5 weeks; after therapy with antibiotics and sulfonamides - 4 weeks; post-dysenteric colitis, follow-up treatment of convalescents after acute intestinal infections, intestinal dysfunction of unknown etiology - 4-8 weeks; nonspecific ulcerative colitis, chronic colitis and enterocolitis - 4-6 weeks. In obstetric and gynecological practice, lactobacilli are used intravaginally. The contents of the Symbiolact compositum sachet are dissolved in 20 ml of boiled water at room temperature. The resulting suspension is impregnated with a gauze swab, which is inserted intravaginally. For chronic inflammatory diseases of the genitals, lactobacilli are administered at night, starting from the 10-12th day of the menstrual cycle. Treatment with Symbiolact compositum is carried out over 3 menstrual cycles. For prenatal preparation of pregnant women at risk, lactobacilli are prescribed for sanitization of the genital tract (for nonspecific inflammatory diseases of the genitals). Symbiolact compositum is prescribed intravaginally once a day for 2-3 weeks. Treatment is carried out under the control of restoration of the purity of vaginal secretions, the appearance of lactoflora and the disappearance of clinical symptoms of the disease. In urological practice, Symbiolact compositum is used intraurethrally.
Contraindications
— individual intolerance (including a history of hypersensitivity) to the components of Symbiolact compositum; - lactose intolerance.
Use during pregnancy and lactation
Symbiolact Compositum can be used during pregnancy and lactation.
special instructions
Symbiolact compositum should not be dissolved in hot water. Store in dissolved form for no more than 20 minutes.
Shelf life and storage conditions
Store in a dry place at room temperature. Shelf life: 2 years.
Vacation category
Over the counter.
Indications
Symbiolact Compositum is intended for the treatment of adults and children, starting from the first days of life. Symbiolact compositum is used both as monotherapy and as part of complex microbiological therapy: intestinal dysbiosis (intestinal dysbiosis), including due to the use of antibiotics, sulfonamide drugs and other chemotherapeutic agents; chronic colitis of various etiologies, including ulcerative colitis and Crohn's disease; previous acute intestinal infections; chronic enterocolitis; irritable bowel syndrome; traveler's diarrhea, acute diarrhea; constipation, flatulence; sanitation of the genital tract for nonspecific inflammatory diseases of the genitals; prenatal preparation of pregnant women of the “risk” group with violation of vaginal cleanliness of the III-IV degree; chronic infections of the genitourinary system (cystitis, prostatitis, vaginitis, urethritis); mycoses of the oral cavity, intestines, skin, nails, hair, vagina; chronic and recurrent diseases of the respiratory tract and ENT organs (bronchitis, rhinitis, sinusitis, tonsillitis, otitis media); atopic diseases (atopic dermatitis/neurodermatitis, allergic rhinoconjunctivitis, bronchial asthma); allergies (including food allergies), allergosis; chronic inflammatory skin diseases (acne, furunculosis).
Symbiolact Compositum 2 g, 30 pack.
Composition 2 g of powder contains: lyophilized mixture of cultures of probiotic and lactic acid microorganisms (microbial mass of bifidobacteria and lactobacilli): Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Bifidobacterium lactis, Lactococcus lactis, Lactobacillus salivarius. Packaging The package contains 30 sachets of 2 g each. Pharmacological action: Symbiolact Compositum is a probiotic to maintain healthy microflora. Symbiolact compositum has a normalizing effect on the intestinal microflora: it maintains and regulates the physiological balance of the intestinal microflora (microbiocenosis) and ensures its physiological functions in the intestine. The therapeutic effect of Symbiolact compositum is determined by living lactobacilli and bifidobacteria, which act as antagonists against a wide range of pathogenic and opportunistic microorganisms. Lactic acid bacteria, which are part of Symbiolact Compositum, produce lactic and, to a lesser extent, acetic and propylene acid. The acidic environment created in the intestines is unfavorable for the development of pathogenic and opportunistic microorganisms. Lactic acid bacteria are involved in the resorption of monosaccharides, the metabolism of bile acids, stabilize the membranes of intestinal epithelial cells and regulate the absorption of electrolytes and the synthesis of vitamins (vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin K, vitamin E, vitamin PP, ascorbic acid, biotin) ; create favorable conditions for the absorption of iron, calcium, vitamin D (vitamin D2, vitamin D3). The use of Symbiolact compositum facilitates the digestion of proteins; Bifidobacterium phosphoprotein phosphatase is involved in the metabolism of milk casein. The activity of intestinal microflora can be disrupted due to a number of factors: taking certain medications (antibiotics, laxatives); unbalanced diet with a large amount of industrially prepared and high-calorie foods containing few ballast substances; stress and tension, smoking and alcohol abuse; intoxication with substances coming from the environment. The consequence of all this may be a violation of the harmonious balance of the microflora composition. Indications: Symbiolact compositum is intended for the treatment of adults and children, starting from the first days of life. Symbiolact compositum is used both as monotherapy and as part of complex microbiological therapy: - intestinal dysbiosis (intestinal dysbiosis), including due to the use of antibiotics, sulfa drugs and other chemotherapeutic agents; — chronic colitis of various etiologies, including nonspecific ulcerative colitis and Crohn’s disease; - previous acute intestinal infections; — chronic enterocolitis; - irritable bowel syndrome; - traveler's diarrhea, acute diarrhea; - constipation, flatulence; — sanitation of the genital tract for nonspecific inflammatory diseases of the genitals; — prenatal preparation of pregnant women at risk with violation of vaginal cleanliness of the III-IV degree; — chronic infections of the genitourinary system (cystitis, prostatitis, vaginitis, urethritis); - mycoses of the oral cavity, intestines, skin, nails, hair, vagina; — chronic and recurrent diseases of the respiratory tract and ENT organs (bronchitis, rhinitis, sinusitis, tonsillitis, otitis media); — atopic diseases (atopic dermatitis/neurodermatitis, allergic rhinoconjunctivitis, bronchial asthma); — allergies (including food allergies), allergosis; - chronic inflammatory skin diseases (acne, furunculosis). Contraindications: - individual intolerance (including a history of hypersensitivity) to the components of Symbiolact compositum; - lactose intolerance. Directions for use and dosage Adults: mix the contents of 1 sachet of Symbiolact compositum (2 g) with 1/2 glass of water (100 ml) at room temperature and take 1-2 times a day with food. Children: mix with warm milk or water (100 ml) and take 1 time per day with food. For infants - immediately before breastfeeding, mixed with breast milk. Single doses of Symbiolact compositum for children (for 1 dose): from the first days of life to 6 months – 1/6 sachet; from 6 months to 2 years – 1/4 sachet; from 2 to 6 years - 1/3 sachet; from 6 to 10 years – 1/2 sachet; over 10 years – 1 sachet. As a rule, the course of treatment with Symbiolact compositum is from 4 to 8 weeks: intestinal dysbiosis (dysbacteriosis) - 4-5 weeks; after therapy with antibiotics and sulfonamides - 4 weeks; post-dysenteric colitis, follow-up treatment of convalescents after acute intestinal infections, intestinal dysfunction of unknown etiology - 4-8 weeks; nonspecific ulcerative colitis, chronic colitis and enterocolitis - 4-6 weeks. In obstetric and gynecological practice, lactobacilli are used intravaginally. The contents of the Symbiolact compositum sachet are dissolved in 20 ml of boiled water at room temperature. The resulting suspension is impregnated with a gauze swab, which is inserted intravaginally. For chronic inflammatory diseases of the genitals, lactobacilli are administered at night, starting from the 10-12th day of the menstrual cycle. Treatment with Symbiolact compositum is carried out over 3 menstrual cycles. For prenatal preparation of pregnant women at risk, lactobacilli are prescribed for sanitization of the genital tract (for nonspecific inflammatory diseases of the genitals). Symbiolact compositum is prescribed intravaginally once a day for 2-3 weeks. Treatment is carried out under the control of restoration of the purity of vaginal secretions, the appearance of lactoflora and the disappearance of clinical symptoms of the disease. In urological practice, Symbiolact compositum is used intraurethrally. Special instructions Do not dissolve Symbiolact compositum in hot water! Store in dissolved form for no more than 20 minutes! Before using Symbiolact compositum, you should consult your doctor.
Mode of application
Adults: mix the contents of 1 sachet of Symbiolact Compositum (2 g) with 1/2 glass of water (100 ml) at room temperature and take 1-2 times a day with food during meals. Children: mix the dietary supplement Symbiolact compositum with warm milk or water (100 ml) and take 1 time per day with food. For infants - immediately before breastfeeding, mixed with breast milk. Single doses of the dietary supplement Symbiolact compositum for children (for 1 dose): from the first days of life to 6 months – 1/6 sachet; from 6 months to 2 years – 1/4 sachet; from 2 to 6 years - 1/3 sachet; from 6 to 10 years – 1/2 sachet; over 10 years – 1 sachet. As a rule, the course of treatment with the dietary supplement Symbiolact compositum ranges from 4 to 8 weeks: intestinal dysbiosis (dysbacteriosis) - 4-5 weeks; after therapy with antibiotics and sulfonamides - 4 weeks; post-dysenteric colitis, follow-up treatment of convalescents after acute intestinal infections, intestinal dysfunction of unknown etiology - 4-8 weeks.
